Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is
MoreNew program combines human hello to digital embrace for long-term medication support Boston, MA – Medisafe, a leading digital drug companion company, is
MoreDavis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million
MoreManufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits SIRIO Europe (Ayanda) – the European nutraceutical
MoreChippenham, UK: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence
MoreMedisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug
MoreNew clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has
MoreNanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a
MorePublishers responsible for tens of thousands of peer-reviewed journals and books have signed an agreement to take a proactive stance
MoreEncouragingly, the industry might be 30% along its sustainability journey, but greater interoperability needed from materials to devices for the
MoreABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair ABX464,
More